Ontology highlight
ABSTRACT:
SUBMITTER: Wu HM
PROVIDER: S-EPMC2824443 | biostudies-literature | 2010 Jan
REPOSITORIES: biostudies-literature
Wu Haifeng M HM Xu Lihui L Sedmak Daniel D DD Marsh Clay B CB Wurster Mark W MW
Personalized medicine 20100101 1
In terms of managing thrombotic disorders, genotype-based individualized patient care emerged as early as 1994 when the association of factor V Leiden (G1691A), and later, prothrombin (G20210A), with thrombotic phenotypes were discovered. Since then, genetic tests for specific thrombophilic SNPs have been routinely incorporated into daily practices in both thrombotic risk assessment and clinical decision-making with respect to prophylactic anti-thrombotic therapy. Recently, the area of pharmacog ...[more]